UFF
KNSA icon

USA Financial Formulas’s Kiniksa Pharmaceuticals KNSA Stock Holding History

USA Financial Formulas’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.7K Sell
533
-124
-19% -$5.49K ﹤0.01% 241
2025
Q4 		$27.1K Sell
657
-159
-19% -$6.38K ﹤0.01% 250
2025
Q3 		$31.7K Buy
+816
New +$26.5K 0.01% 234

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

USA Financial Formulas's KNSA Position: Q1 2026 in Review

USA Financial Formulas reduced its Kiniksa Pharmaceuticals (KNSA) stake by 19% in Q1 2026, selling an estimated $5.49K and leaving 533 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

USA Financial Formulas first reported a position in KNSA in Q3 2025 and has held it in 3 quarters since. The position peaked at $31.7K in Q3 2025. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • USA Financial Formulas held 533 shares of Kiniksa Pharmaceuticals worth $25.7K as of Q1 2026.
  • USA Financial Formulas sold 124 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $5.49K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #241 holding.
  • USA Financial Formulas first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • USA Financial Formulas's Kiniksa Pharmaceuticals position peaked at $31.7K in Q3 2025.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.